Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2006 | 2007 | 2009 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$163.0K | −$148.0K | −$65.0K | −$13.0K | −$27.2K | −$33.6K | −$39.3K | −$78.1M |
| EBITDA | −$163.0K | −$148.0K | −$65.0K | −$13.0K | −$27.2K | $138.2K | −$9.0M | −$77.8M |
| Net income | −$163.0K | −$148.0K | −$65.0K | −$13.0K | −$18.6K | −$33.6K | −$101.0M | −$78.1M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -10.14 | -9.21 | -40.45 | -0.00 | -0.00 | -0.00 | -0.35 | -0.26 |
Annual figures · source: Financial Modeling Prep
NUNZIA PHARMACEUTICL CORP
No one on the platform currently holds NUNZ.
No tracked institution reports a position in NUNZ as of their last filing.
No one on the platform has traded NUNZ yet.
| +0.00% |
| $4914 |
| — |
| NNRXNutranomics, Inc. | $0.00 | +0.00% | $816232 | — |
| ONSSOnassis Holdings Corp. | $0.00 | +49.25% | $3926 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.